|
Jul 28
|
RBC Capital Lowered the PT on MannKind Corporation (MNKD), Kept a Buy Rating
|
|
Jul 23
|
MannKind Corporation (MNKD) Presented Inhaled Insulin Therapy At American Diabetes Association
|
|
Feb 19
|
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
|
|
Feb 6
|
MannKind to Present at Upcoming Investor Conferences
|